¼¼°èÀÇ ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀå
Cervical Cancer Endoscopic Devices
»óǰÄÚµå : 1536164
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 177 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀº 2030³â±îÁö 12¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 9¾ï 3,630¸¸ ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀº 2030³â¿¡´Â 12¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ±¤ÇÐ ÄÝÆ÷½ºÄÚÇÁ´Â CAGR 2.9%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 6¾ï 6,810¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µðÁöÅÐ ÄÝÆ÷½ºÄÚÇÁÀÇ ¼ºÀå·üÀº CAGR 4.0%ÀÔ´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 2¾ï 5,510¸¸ ´Þ·¯, Áß±¹Àº CAGR 6.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀº 2023³â 2¾ï 5,510¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2¾ï 4,230¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 6.4%·Î Àü¸ÁµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.1%¿Í 2.5%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ

¼¼°èÀÇ ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀº ·Îº¿ Áö¿ø ¼ö¼úÀÇ Ã¤¿ë Áõ°¡¿Í Àúħ½À ¼ö¼ú ¼ö¿ä Áõ°¡¿¡ °ßÀεǾî ÇâÈÄ ¼ö³â°£ Å©°Ô ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ±â¼úÀº ±ÙÄ¡Àû Àڱà ÀýÁ¦¼ú°ú °°Àº ÀýÂ÷ÀÇ È¿´ÉÀ» ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó °ü·Ã ºñ¿ë, ÇÕº´Áõ, ȸº¹ ½Ã°£À» ÁÙÀ̰í ȯÀÚ¿¡°Ô ÀýÂ÷¸¦ ´õ ½±°Ô »ç¿ëÇÏ°í °ü¸®Çϱ⠽±½À´Ï´Ù. ÀÌ·¯ÇÑ Àúħ½À¼º ÀÇ·á °³ÀÔÀ¸·ÎÀÇ ÀüȯÀº ÀÔ¿ø ±â°£À» ´ÜÃàÇϰí ÀçȰ ºñÀ²À» Áõ°¡½ÃŰ°í ½ÃÀå ³» Ãß°¡ ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÛ°í À¯¿¬ÇÑ ³»½Ã°æ ½ÃÀå °³Ã´Àº ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±æÀ» ¿­°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ´õ ³ÐÀº ¹üÀ§¸¦ ´Ù·ç°í ¿Ü»ó À§ÇèÀ» ÁÙÀ̱⠶§¹®¿¡ ±âÁ¸ÀÇ ´Ü´ÜÇÑ ¸ðµ¨º¸´Ù ¼±È£µË´Ï´Ù.

ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀº Á¶±â Áø´Ü ¹× ¹ß°ß ¼Ö·ç¼ÇÀÇ Á¸Àç¿¡ ÀÇÇØ ÃËÁøµÈ Àڱà °æºÎ¾ÏÀÇ Á¤±â °ËÁøÀ» ¹Þ´Â ¿©¼º Áõ°¡¿¡ ÀÇÇØ ´õ¿í Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ÄèÀûÇÑ Áø´Ü Àåºñ¿Í Àúħ½À ±â¼úÀÇ ¹ßÀüÀ¸·Î °ËÁøÀÌ ´õ ¾î·Á¿öÁö°í ´õ ÀÏ»óÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ¹Ì±¹ º¸°Ç»çȸº¹Áö¼ºÀÌ ¼³Á¤ÇÑ Healthy People 2020ÀÇ ¸ñÇ¥¿Í °°Àº ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖÀ¸¸ç, ÀڱðæºÎ¾Ï °ËÁøÀ» ¹Þ´Â 21¼¼ºÎÅÍ 65¼¼ ¿©¼ºÀÇ ºñÀ²À» 93%±îÁö Áõ°¡½ÃŰ´Â °Í ¸ñÇ¥ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¤Ã¥¿¡ ÀÇÇØ ¿¹¹æÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö°í ÀÖ¾î ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ¼ö¿ä°¡ ´ëÆø ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ô´Ù°¡ ½ÃÀå ¿ªÇÐÀÇ Æ¯Â¡À¸·Î ÀڱðæºÎ¾ÏÀÇ À¯º´·üÀÌ ³ô°í ƯÈ÷ ÀڱðæºÎ¾Ï¿¡ ÀÇÇÑ »ç¸ÁÀÚÀÇ ´ëºÎºÐÀÌ ÁßÀú¼Òµæ±¹¿¡¼­ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áúº´ÀÇ ¼¼°è À¯º´·ü Áõ°¡´Â È¿°úÀûÀÎ Áø´Ü ¹× Ä¡·á ¿É¼ÇÀÇ È®´ë¸¦ ÇÊ¿ä·ÎÇϰí ÀڱðæºÎ¾Ï ³»½Ã°æ ±â±â ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °íÇØ»óµµ 3D ½Ã½ºÅÛ, ĸ½¶ ³»½Ã°æ, ¼ÒÇü ³»½Ã°æ ¸ðµ¨ µî ³»½Ã°æÀÇ ±¤¹üÀ§ÇÑ Àû¿ëÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±â¼ú Çõ½ÅÀÌ »õ·Î¿î ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºÏ¹Ì´Â ÷´Ü °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í Çõ½ÅÀûÀÎ ÀÇ·á ±â¼úÀÇ ±¤¹üÀ§ÇÑ µµÀÔ ¿Ü¿¡µµ ºÎÀΰú ÀåºñÀÇ ÀÔ¼ö¸¦ ¿ëÀÌÇϰÔÇÏ´Â Á¤ºÎ ¹× ¹Î°£ º¸ÇèÀÇ Æ²ÀÌ µÞ¹ÞħµÇ±â ¶§¹®¿¡ ¾ÕÀ¸·Îµµ ÁÖµµÀû ½ÃÀåÀÌ °è¼Ó µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 86°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cervical Cancer Endoscopic Devices Market to Reach US$1.2 Billion by 2030

The global market for Cervical Cancer Endoscopic Devices estimated at US$936.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the end of the analysis period. Growth in the Digital Colposcopes segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$255.1 Million While China is Forecast to Grow at 6.4% CAGR

The Cervical Cancer Endoscopic Devices market in the U.S. is estimated at US$255.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$242.3 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Key Trends and Drivers

The global cervical cancer endoscopic devices market is poised for significant growth in the coming years, driven by the increasing adoption of robotic-assisted surgeries and the rising demand for minimally invasive surgical procedures. These advanced technologies not only enhance the efficacy of procedures such as radical hysterectomies but also reduce the associated costs, complications, and recovery times, making the procedures more accessible and manageable for patients. This shift towards less invasive medical interventions is expected to reduce hospital stays and increase rates of rehabilitation, fueling further demand within the market. Additionally, the development of downsized and flexible endoscopes is creating new avenues for market growth, as these devices offer greater coverage and reduce the risk of trauma, enhancing their preference over traditional rigid models.

The cervical cancer endoscopic devices market is further buoyed by an increasing number of women undergoing regular screenings for cervical cancer, facilitated by the presence of early diagnostic and detection solutions. With advancements in comfortable diagnostic equipment and minimally invasive techniques, screenings are becoming less daunting and more routine, which is likely to increase the number of screenings conducted. This trend is supported by initiatives like the Healthy People 2020 goals set by the U.S. Department of Health and Human Services, which aim to increase the percentage of women aged 21 to 65 who undergo cervical cancer screenings to 93 percent. Such policies underscore the growing focus on preventive healthcare and are expected to significantly boost demand for cervical cancer endoscopic devices.

Moreover, the market dynamics are characterized by the high prevalence of cervical cancer, particularly in low- and middle-income countries where the majority of cervical cancer fatalities occur. The increasing prevalence of the disease globally necessitates the expansion of effective diagnostic and treatment options, thereby propelling the market for cervical cancer endoscopic devices. Technological innovations that allow for a broader application of endoscopy, such as high-resolution 3D systems, capsule endoscopy, and miniature endoscopy models, are anticipated to offer new growth opportunities. North America is expected to remain a leading market due to its advanced healthcare infrastructure and widespread adoption of innovative medical technologies, alongside supportive government and private insurance frameworks that facilitate the acquisition of gynecological devices.

Select Competitors (Total 86 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â